Prostacyclin for pulmonary hypertension.

Author: LassersonT J, ParamothayanN S, WaltersE H, WellsA U

Paper Details 
Original Abstract of the Article :
Primary pulmonary hypertension (PPH) is progressive, resulting in right ventricular failure. Survival seldom exceeds five years. Pulmonary hypertension can be idiopathic or associated with other conditions. It is common in patients with diffuse scleroderma and the CREST syndrome where it is clinical...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1002/14651858.CD002994

データ提供:米国国立医学図書館(NLM)

Prostacyclin for Pulmonary Hypertension: A Ray of Hope in a Challenging Condition

Pulmonary hypertension, a condition characterized by high blood pressure in the arteries of the lungs, is a serious and often life-threatening disease. It can be idiopathic, meaning it has no known cause, or associated with other conditions, such as scleroderma. This review focuses on the use of prostacyclin, a powerful vasodilator and inhibitor of platelet aggregation, in the management of pulmonary hypertension. Iloprost, a stable derivative of prostacyclin, is administered orally, by infusion, or by inhalation. This review highlights the potential benefits of prostacyclin therapy for individuals with pulmonary hypertension.

Prostacyclin Therapy: A Powerful Tool for Vasodilation

Prostacyclin therapy has shown promise in alleviating the symptoms of pulmonary hypertension, particularly in individuals with scleroderma. This review emphasizes that prostacyclin, like a refreshing oasis in the desert, can provide relief from the debilitating effects of pulmonary hypertension. This medication's ability to dilate blood vessels and inhibit platelet aggregation offers hope for improving the quality of life for patients.

Managing Pulmonary Hypertension: A Multifaceted Approach

The treatment of pulmonary hypertension requires a multifaceted approach, including lifestyle modifications, medications, and in some cases, surgery. Prostacyclin therapy plays an important role in this management plan, offering a valuable tool for managing the symptoms and improving the overall health of individuals with this challenging condition. This review underscores the importance of early diagnosis and effective treatment for this serious illness.

Dr. Camel's Conclusion

Pulmonary hypertension, like a desert mirage, can be a deceptive and daunting challenge. However, the advent of prostacyclin therapy offers a beacon of hope, providing relief from the debilitating symptoms of this disease. This review reminds us that even in the harsh realities of medical conditions, innovation and advancements continue to emerge, offering a path toward improved health and well-being.

Date :
  1. Date Completed 2003-07-28
  2. Date Revised 2020-05-11
Further Info :

Pubmed ID

12804447

DOI: Digital Object Identifier

10.1002/14651858.CD002994

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.